Jon joined Advent in 2018 and brings 20+ years of experience from some of the leading biotech companies in the UK.

He has a track record of success in early-stage drug discovery against first in class targets, the application of gene editing to drug discovery, developing new therapeutic technology platforms and in business development, most recently serving as CSO of Horizon Discovery. Since joining Advent, he has concentrated on newco creation, serving first as the founding CEO of Pheno Therapeutics and he is now the founding CEO of cancer immune-therapeutics company Epitopea.

Jon is originally a biochemist and cell biologist with a PhD from the University of Newcastle upon Tyne and extensive postdoctoral experience in academia including 4 years with Nobel Laureate, Tim Hunt.

Back to Team